Phoenix Molecular Designs
  • About US Mission & Vision Management Team Board of Directors Advisory Board
  • Science Precision Medicine Scientific Posters Publications
  • Pipeline
  • Media Latest News
  • About Trial Details
  • Patient Resources
  • Contact
Phoenix Molecular Designs
  • About/
    • About US
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Advisory Board
  • Our Science/
    • Science
    • Precision Medicine
    • Scientific Posters
    • Publications
  • Pipeline/
  • Investors & media/
    • Media
    • Latest News
  • Phase 2 Clinical Trial/
    • About
    • Trial Details
  • Patient Resources/
  • Contact/
tubes_red Watermarked.jpg
Phoenix Molecular Designs

Personalized and alternative cancer therapeutics for quality of life

Media

Phoenix Molecular Designs
  • About/
    • About US
    • Mission & Vision
    • Management Team
    • Board of Directors
    • Advisory Board
  • Our Science/
    • Science
    • Precision Medicine
    • Scientific Posters
    • Publications
  • Pipeline/
  • Investors & media/
    • Media
    • Latest News
  • Phase 2 Clinical Trial/
    • About
    • Trial Details
  • Patient Resources/
  • Contact/
August 29, 2013

Exploring Alcoholism Drug’s Potential Against Brain Tumors

August 29, 2013/ Guest User

November 29, 2012 - Dr. Sandra Dunn's team at UBC department of paediatrics simultaneously publishes data that corresponds with $2.5 million grant winning research at Swedish Medical Center identifying Disulfaram as having potential for brain cancer treatment.

Read the full article here ...

August 29, 2013/ Guest User/

Guest User

  • Groundbreaking research in ...
  • Stem Cell Killer Could Lead to ...
Contact us

2024© Phoenix Molecular Designs